Andreas Krebs
CIK 1438946 · President, EMEA & Canada · last filed 2025-06-16
Andreas Krebs is a President, EMEA & Canada who has filed 8 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for MNMD, was dated Jun 16, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 15,107 | $15.00 | $226.6K | $0 | 5 | 2025-06-16 |
| WYETH (WYEp.CL) Delisted | President, EMEA & Canada | 15,807 | — | — | $0 | 1 | 2009-04-29 |
| WYETH (WYEp) Delisted | President, EMEA & Canada | 18,432 | — | — | $0 | 1 | 2009-03-03 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +13,671 | $0 | EDGAR |
| 2022-06-06 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +21,552 | $0 | EDGAR |
| 2022-06-03 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +21,552 | $0 | EDGAR |
| 2009-10-19 | — | Disp (D) | −15,882 | -$200.3K | |
| 2009-04-29 | WYETH (WYEp.CL) Delisted | Tax (F) | −921 | -$38.8K | EDGAR |
| 2009-03-03 | WYETH (WYEp) Delisted | Mixed | +2,251 | -$70.8K | EDGAR |